title: Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline.
abstract: The mechanisms by which aniline exposure elicits splenotoxic response, especially the tumorigenic response, are not well-understood. Splenotoxicity of aniline is associated with iron overload and generation of reactive oxygen species (ROS) which can cause oxidative damage to DNA, proteins and lipids (oxidative stress). 8-Hydroxy-2'-deoxyguanosine (8-OHdG) is one of the most abundant oxidative DNA lesions resulting from ROS, and 8-oxoguanine glycosylase 1 (OGG1), a specific DNA glycosylase/lyase enzyme, plays a key role in the removal of 8-OHdG adducts. This study focused on examining DNA damage (8-OHdG) and repair (OGG1) in the spleen in an experimental condition preceding a tumorigenic response. To achieve that, male Sprague-Dawley rats were subchronically exposed to aniline (0.5 mmol/kg/day via drinking water for 30 days), while controls received drinking water only. Aniline treatment led to a significant increase in splenic oxidative DNA damage, manifested as a 2.8-fold increase in 8-OHdG levels. DNA repair activity, measured as OGG1 base excision repair (BER) activity, increased by approximately 1.3 fold in the nuclear protein extracts (NE) and approximately 1.2 fold in the mitochondrial protein extracts (ME) of spleens from aniline-treated rats as compared to the controls. Real-time PCR analysis for OGG1 mRNA expression in the spleen revealed a 2-fold increase in expression in aniline-treated rats than the controls. Likewise, OGG1 protein expression in the NEs of spleens from aniline-treated rats was approximately 1.5 fold higher, whereas in the MEs it was approximately 1.3 fold higher than the controls. Aniline treatment also led to stronger immunostaining for both 8-OHdG and OGG1 in the spleens, confined to the red pulp areas. It is thus evident from our studies that aniline-induced oxidative stress is associated with increased oxidative DNA damage. The BER pathway was also activated, but not enough to prevent the accumulation of oxidative DNA damage (8-OHdG). Accumulation of mutagenic oxidative DNA lesions in the spleen following exposure to aniline could play a critical role in the tumorigenic process.
authors.affiliation: Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555-0438, USA.
authors.forename: Huaxian
authors.initials: H
authors.lastname: Ma
authors.forename: Jianling
authors.initials: J
authors.lastname: Wang
authors.forename: Sherif Z
authors.initials: SZ
authors.lastname: Abdel-Rahman
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Boor
authors.forename: M Firoze
authors.initials: MF
authors.lastname: Khan
mesh_terms: D000080242:8-Hydroxy-2'-Deoxyguanosine; D000814:Aniline Compounds / Q000633:toxicity*; D000818:Animals; D002273:Carcinogens / Q000633:toxicity*; D004249:DNA Damage / Q000187:drug effects*; D045647:DNA Glycosylases / Q000378:metabolism; D004260:DNA Repair; D003849:Deoxyguanosine / Q000031:analogs & derivatives / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D008297:Male; D024101:Mitochondrial Proteins / Q000378:metabolism; D009153:Mutagens / Q000633:toxicity; D009687:Nuclear Proteins / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013154:Spleen / Q000187:drug effects* / Q000473:pathology
chemical_list: D000814:Aniline Compounds; D002273:Carcinogens; D024101:Mitochondrial Proteins; D009153:Mutagens; D009687:Nuclear Proteins; D012333:RNA, Messenger; D000080242:8-Hydroxy-2'-Deoxyguanosine; D045647:DNA Glycosylases; C483741:OGG1 protein, rat; D003849:Deoxyguanosine; C023650:aniline
references.citation: J Biol Chem. 1992 Jan 5;267(1):166-72
references.pmid: 1730583
references.citation: Carcinogenesis. 2007 Aug;28(8):1629-37
references.pmid: 17389610
references.citation: Carcinogenesis. 1998 Jun;19(6):1053-9
references.pmid: 9667744
references.citation: Prog Nucleic Acid Res Mol Biol. 2001;68:41-54
references.pmid: 11554312
references.citation: Nucleic Acids Res. 2001 Jan 15;29(2):430-8
references.pmid: 11139613
references.citation: Nucleic Acids Res. 2004 Aug 13;32(14):4332-9
references.pmid: 15310837
references.citation: J Clin Invest. 2002 Jan;109(1):3-6
references.pmid: 11781342
references.citation: J Natl Cancer Inst. 1984 Jul;73(1):265-73
references.pmid: 6588231
references.citation: Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):86-93
references.pmid: 16169568
references.citation: Int J Cancer. 2005 Mar 10;114(1):153-6
references.pmid: 15523686
references.citation: Toxicol Appl Pharmacol. 2008 May 1;228(3):395-402
references.pmid: 18234257
references.citation: Carcinogenesis. 2001 Sep;22(9):1459-63
references.pmid: 11532868
references.citation: Nature. 2000 Feb 24;403(6772):859-66
references.pmid: 10706276
references.citation: J Toxicol Environ Health A. 2005 Apr 23;68(8):657-66
references.pmid: 15901093
references.citation: Methods. 2001 Dec;25(4):443-51
references.pmid: 11846613
references.citation: Mol Vis. 2000 Oct 05;6:178-83
references.pmid: 11023552
references.citation: Nucleic Acids Res. 1998 Nov 15;26(22):5116-22
references.pmid: 9801308
references.citation: Cancer Res. 2003 Aug 15;63(16):4899-902
references.pmid: 12941813
references.citation: Arch Environ Contam Toxicol. 1993 Apr;24(3):368-74
references.pmid: 8470936
references.citation: J Toxicol Environ Health A. 2003 Jan 10;66(1):93-102
references.pmid: 12587293
references.citation: Mol Carcinog. 1999 Dec;26(4):254-60
references.pmid: 10569802
references.citation: Cancer Res. 1994 Apr 1;54(7 Suppl):1890s-1894s
references.pmid: 8137306
references.citation: Toxicol Appl Pharmacol. 2005 Feb 15;203(1):36-44
references.pmid: 15694462
references.citation: Free Radic Biol Med. 2001 Dec 1;31(11):1465-72
references.pmid: 11728819
references.citation: Am J Physiol Cell Physiol. 2008 Feb;294(2):C413-22
references.pmid: 18077603
references.citation: Clin Cancer Res. 2000 Apr;6(4):1394-400
references.pmid: 10778969
references.citation: Oncogene. 1998 Jun 11;16(23):3083-6
references.pmid: 9662341
references.citation: Carcinogenesis. 2004 Nov;25(11):2177-81
references.pmid: 15284179
references.citation: Toxicology. 2002 May 1;173(3):193-201
references.pmid: 11960672
references.citation: Toxicol Sci. 1999 Mar;48(1):134-40
references.pmid: 10330693
references.citation: Annu Rev Genet. 2004;38:445-76
references.pmid: 15568983
references.citation: Toxicol Sci. 2004 Sep;81(1):198-215
references.pmid: 15187235
references.citation: Mol Gen Genet. 1997 Mar 26;254(2):171-8
references.pmid: 9108279
references.citation: Nucleic Acids Res. 1999 Oct 15;27(20):4001-7
references.pmid: 10497264
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8010-5
references.pmid: 9223305
references.citation: Carcinogenesis. 1990 Sep;11(9):1447-50
references.pmid: 2205403
references.citation: Free Radic Biol Med. 2001 Apr 15;30(8):916-23
references.pmid: 11295534
references.citation: Toxicol Appl Pharmacol. 2008 Jul 15;230(2):227-34
references.pmid: 18420242
references.citation: Biochemistry. 1991 Jan 8;30(1):207-13
references.pmid: 1703014
references.citation: J Toxicol Environ Health A. 1999 Jun 11;57(3):173-84
references.pmid: 10376884
references.citation: Free Radic Biol Med. 1996;20(4):553-66
references.pmid: 8904296
references.citation: Food Chem Toxicol. 1987 Aug;25(8):619-26
references.pmid: 3305247
references.citation: J Natl Cancer Inst. 2003 Sep 3;95(17):1263-5
references.pmid: 12953074
references.citation: Arch Biochem Biophys. 2000 May 1;377(1):1-8
references.pmid: 10775435
references.citation: Mech Ageing Dev. 2006 Jan;127(1):64-9
references.pmid: 16257035
references.citation: J Natl Cancer Inst. 1985 Oct;75(4):681-90
references.pmid: 3862900
references.citation: Mutat Res. 2002 Nov 30;509(1-2):127-51
references.pmid: 12427535
references.citation: Antioxid Redox Signal. 2008 May;10(5):891-937
references.pmid: 18205545
references.citation: Jpn J Cancer Res. 2000 Jul;91(7):681-5
references.pmid: 10920274
references.citation: Mol Cell Biol. 2006 Mar;26(5):1654-65
references.pmid: 16478987
references.citation: J Natl Cancer Inst. 1985 Jul;75(1):81-4
references.pmid: 2989605
references.citation: FASEB J. 2003 Jul;17(10):1195-214
references.pmid: 12832285
references.citation: Fundam Appl Toxicol. 1997 Jan;35(1):22-30
references.pmid: 9024670